My bookmarksSign up free
Source

Commission Regulation (EU) 2017/212 of 7 February 2017 designating the EU reference laboratory for peste des petits ruminants, laying down additional responsibilities and tasks for this laboratory and amending Annex VII to Regulation (EC) No 882/2004 of the European Parliament and of the Council (Text with EEA relevance. )

Commission Regulation (EU) 2017/212 of 7 February 2017 designating the EU reference laboratory for peste des petits ruminants, laying down additional responsibilities and tasks for this laboratory and amending Annex VII to Regulation (EC) No 882/2004 of the European Parliament and of the Council (Text with EEA relevance. )

Regulation (EU) 2017/212 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Centre de coopération internationale en recherche agronomique pour le développement (CIRAD), Montpellier, France is hereby designated as the Union (EU) reference laboratory for peste des petits ruminants. The additional responsibilities and tasks for that laboratory are laid down in the Annex.

Article 2

Open ↗

In Part II of Annex VII to Regulation (EC) No 882/2004, the following point 20 is added: ‘20. EU reference laboratory for peste des petits ruminants ‘Centre de coopération internationale en recherche agronomique pour le développement (CIRAD)’ TA A-15/G, Campus International de Baillarguet 34398 Montpellier Cedex France’.

Article 3

Open ↗

This Regulation shall enter into force on the 20th day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Responsibilities and tasks of the EU reference laboratory for peste des petits ruminants In addition to the general functions and duties of EU reference laboratories in the animal health sector laid down in Article 32(2) of Regulation (EC) No 882/2004 the EU reference laboratory for peste des petits ruminants shall have the following responsibilities and tasks: 1. to ensure liaison between the national reference laboratories of the Member States and to provide optimal methods for the diagnosis of peste des petits ruminants in livestock, specifically by: (a) typing and full antigenic and genomic characterization, phylogenetic analysis (relationship with other strains of the same virus) of viruses and storing strains of peste des petits ruminants viruses to facilitate diagnosis services in the Union and, where relevant and necessary, for example, for epidemiological follow-ups or verification of diagnosis; (b) building up and maintaining an up-to-date collection of strains and isolates of peste des petits ruminants viruses and specific sera and other reagents against the disease when or if available; (c) harmonising the diagnosis and ensuring proficiency of testing within the Union by organising and operating periodic inter-laboratory comparative trials and external quality assurance exercises on the diagnosis of this disease at Union level and by the periodic transmission of the results of such trials to the Commission, the Member States, and the national reference laboratories concerned; (d) retaining expertise on this disease to enable rapid differential diagnosis, in particular, with other relevant viral diseases; (e) carrying out research studies with the objective of developing improved methods of disease control, in collaboration with national reference laboratories designated for this disease, and as agreed by the Commission; (f) advising the Commission on scientific aspects related to peste des petits ruminants and, in particular, on the selection and use of peste des petits ruminants virus vaccine strains. 2. to support the functions of national reference laboratories of the Member States designated for the diagnosis of peste des petits ruminants, in particular by: (a) storing and supplying standard sera and other reference reagents, such as viruses, inactivated antigens or cell lines, to these laboratories in order to standardise the diagnostic tests and the reagents used in each Member State, where identification of the agent and/or the use of serological tests are required; (b) assisting actively in the diagnosis of diseases in connection with the suspicion and confirmation of outbreaks in Member States by receiving isolates of peste des petits ruminants viruses for the purposes of confirmatory diagnosis, virus characterization and contributing to epidemiological investigations and studies. Communicating the results of these activities without delay to the Commission, as well as to the Member States and the national reference laboratories concerned. 3. to provide information and carry out further training, in particular by: (a) facilitating the provision of training, refresher courses and workshops for the benefit of national reference laboratories designated for the diagnosis of peste des petits ruminants and experts in laboratory diagnostics with a view to harmonising diagnostic techniques for this disease throughout the Union; (b) participating in international forums concerning, in particular, the standardisation of analytical methods for this disease and their implementation; (c) collaborating with the relevant competent laboratories in non-EU countries where this disease is prevalent as regards diagnosis methods for peste des petits ruminants; (d) reviewing at the annual meeting of national reference laboratories designated for the diagnosis of peste des petits ruminants the relevant recommendations for testing laid down by the World Organisation for Animal Health (OIE) in the Terrestrial Animal Health Code and in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; (e) assisting the Commission in reviewing the OIE's recommendations laid down in the Terrestrial Animal Health Code and in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; (f) keeping abreast of developments in the epidemiology of peste des petits ruminants.

Other acts of the same type
Regulation (EU) 2021/558 of the European Parliament and of the Council of 31 March 2021 amending Regulation (EU) No 575/2013 as regards adjustments to the securitisation framework to support the economic recovery in response to the COVID-19 crisis (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/551 of 30 March 2021 concerning the authorisation of turmeric extract, turmeric oil, turmeric oleoresin from Curcuma longa L. rhizome as feed additives for all animal species and turmeric tincture from Curcuma longa L. rhizome as a feed additive for horses and dogs (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/552 of 30 March 2021 granting a Union authorisation for the biocidal product family ‘DEC-AHOL® Product Family’ (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/566 of 30 March 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, mepanipyrim, Metarhizium anisopliae (var. anisopliae) strain BIPESCO 5/F52, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium oligandrum M1, rimsulfuron, spinosad, Streptomyces K61 (formerly ‘S. griseoviridis’), Trichoderma asperellum (formerly ‘T. harzianum’) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly ‘T. harzianum’) strain T11, Trichoderma gamsii (formerly ‘T. viride’) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/574 of 30 March 2021 amending Implementing Regulations (EU) 2017/375 and (EU) No 540/2011 as regards the conditions of approval of the active substance prosulfuron (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/575 of 30 March 2021 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2021/546 of 29 March 2021 imposing a definitive anti-dumping duty and definitively collecting the provisional duty imposed on imports of aluminium extrusions originating in the People’s Republic of ChinaCommission Implementing Regulation (EU) 2021/547 of 29 March 2021 amending Implementing Regulation (EU) 2019/1715 as regards procedures for the establishment and use of ADIS and EUROPHYT, the issuance of electronic animal health certificates, official certificates, animal health/official certificates and commercial documents, the use of electronic signatures, and the functioning of TRACES, and repealing Decision 97/152/EC (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/548 of 29 March 2021 making imports of optical fibre cables originating in the People’s Republic of China subject to registrationCommission Implementing Regulation (EU) 2021/549 of 29 March 2021 amending for the 319th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCouncil Implementing Regulation (EU) 2021/538 of 26 March 2021 implementing Article 21(2) of Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in LibyaCommission Implementing Regulation (EU) 2021/550 of 26 March 2021 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Radicchio Rosso di Treviso’ (PGI))

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next